Model Evaluation Program Now Includes p53 and Bcrp TGEM® Knockout Rats
April 12, 2012 - Available exclusively from Charles River, receive an evaluation order of the p53 or Bcrp TGEM® knockout rat models as part of the Charles River Model Evaluation Program, implemented to provide you a risk-free, cost-effective way of determining if our models are right for your research. To place your order, complete our Model Evaluation Request Form.
Overview of Models
The p53 TGEM® knockout rat [Crl:WI(UL)-Tp53m1/Hubr] develops a variety of malignant tumors, including sarcomas and lymphomas. This model’s tumor onset and mortality statistics improve timelines for carcinogenicity testing. To learn more, click here.
The Bcrp TGEM® knockout rat [Crl:WI(UL)-Abcg2m1/Hubr] carries a mutation within the catalytic center ABC transporter-like domain of the rat Abcg2 (BCRP) gene, eliminating all wild-type protein. In vivo drug transport studies conducted in this rat model will enhance the ability to predict how drug candidates will perform in humans. To learn more, click here.
For more information about the p53 or Bcrp TGEM® knockout rats or questions on placing an evaluation order, please contact us at firstname.lastname@example.org.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
Clinical pathology data can assist you in selecting the most appropriate model for your study and can provide important information on the physiology and health of your research animals.
We are now the exclusive distributor of the TARGATT™ mouse. The TARGATT mouse is a transgenic mouse designed to produce animal models with investigator designed exogenous DNA sequences knocked-in to a specific site.
Jun 10–Jun 13
Visit us in booth #091 to learn more about our recent innovations including expanded diagnostic capabilities, a new online portal connecting clients with their colonies and a deep-rooted commitment to humane care.
May 28–Jun 01
The International Bone and Mineral Society (IBMS) and the Japanese Society for Bone and Mineral Research (JSBMR) are excited to sponsor the second joint scientific meeting by the two organizations.
May 27–May 29
Charles River and the René Remie Surgical Skills Centre (RRSSC) have joined their expertise and are pleased to offer a 3-day surgery training course. Held at the RRSSC in the Netherlands, this training is designed to be very practical and combines lectures with hands-on exercises, ensuring you receive the most comprehensive training experience. This course is recommended for simple procedures only (e.g., simple exeresis, simple catheterizations such as jugular vein or femoral vein, simple ALZET pump implantation, ECG radiotelemetry).
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
Charles River Laboratories, Inc.